BIOMAT Database Logo BIOMAT Database Logo

Absence of fosfomycin resistance in gastrointestinal Escherichia coli following fosfomycin therapy. 2018

Roberta T Mettus, and Sarah L Bowler, and Serena F Kantz, and Christi L McElheny, and A William Pasculle, and Yohei Doi
Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

UI MeSH Term Description Entries
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005578 Fosfomycin An antibiotic produced by Streptomyces fradiae. Phosphonomycin,Fosfomycin Trometamol Salt,Fosfomycin Tromethamine,Monuril,Phosphomycin,Tromethamine, Fosfomycin
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D041981 Gastrointestinal Tract Generally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs (LIVER; BILIARY TRACT; PANCREAS). Digestive Tract,GI Tract,Digestive Tracts,GI Tracts,Gastrointestinal Tracts
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Roberta T Mettus, and Sarah L Bowler, and Serena F Kantz, and Christi L McElheny, and A William Pasculle, and Yohei Doi
Fosfomycin resistance in Escherichia coli in Japan.
September 1998, The Journal of antibiotics,
Roberta T Mettus, and Sarah L Bowler, and Serena F Kantz, and Christi L McElheny, and A William Pasculle, and Yohei Doi
Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA.
November 2015, Emerging infectious diseases,
Roberta T Mettus, and Sarah L Bowler, and Serena F Kantz, and Christi L McElheny, and A William Pasculle, and Yohei Doi
Rapid Detection of Fosfomycin Resistance in Escherichia coli.
January 2019, Journal of clinical microbiology,
Roberta T Mettus, and Sarah L Bowler, and Serena F Kantz, and Christi L McElheny, and A William Pasculle, and Yohei Doi
How is fosfomycin resistance developed in Escherichia coli?
December 2018, Future microbiology,
Roberta T Mettus, and Sarah L Bowler, and Serena F Kantz, and Christi L McElheny, and A William Pasculle, and Yohei Doi
Molecular insights into fosfomycin resistance in Escherichia coli.
May 2017, The Journal of antimicrobial chemotherapy,
Roberta T Mettus, and Sarah L Bowler, and Serena F Kantz, and Christi L McElheny, and A William Pasculle, and Yohei Doi
Fosfomycin resistance plasmids do not affect fosfomycin transport into Escherichia coli.
April 1982, Antimicrobial agents and chemotherapy,
Roberta T Mettus, and Sarah L Bowler, and Serena F Kantz, and Christi L McElheny, and A William Pasculle, and Yohei Doi
Fosfomycin causes transient lysis in Escherichia coli strains carrying fosfomycin-resistance plasmids.
December 1985, Journal of general microbiology,
Roberta T Mettus, and Sarah L Bowler, and Serena F Kantz, and Christi L McElheny, and A William Pasculle, and Yohei Doi
Fosfomycin in vitro resistance of Escherichia coli from the community.
January 2011, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,
Roberta T Mettus, and Sarah L Bowler, and Serena F Kantz, and Christi L McElheny, and A William Pasculle, and Yohei Doi
Biological costs and mechanisms of fosfomycin resistance in Escherichia coli.
September 2003, Antimicrobial agents and chemotherapy,
Roberta T Mettus, and Sarah L Bowler, and Serena F Kantz, and Christi L McElheny, and A William Pasculle, and Yohei Doi
Fosfomycin inactivates its target enzyme in Escherichia coli cells carrying a fosfomycin resistance plasmid.
August 1983, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!